Kathy M. McGee - 06 Jul 2021 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: Chief Operating Officer
Signature: /s/ Donna Shiroma, by power of attorney
Issuer symbol: RCEL
Transactions as of: 06 Jul 2021
Net transactions value: $0
Form type: 4
Filing time: 07 Sep 2021, 16:05:34 UTC
Previous filing: 25 May 2021
Next filing: 06 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Award		+10,500			10,500	06 Jul 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCEL	Stock Options (Right to Buy)	Award	$0	+6,925		$0.000000	6,925	06 Jul 2021	Common Stock	6,925	$20.21	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-vesting criteria with respect to the particular portion of Restricted Stock Units.
F2	These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.